PMID: 11903513Mar 21, 2002Paper

Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers

Fundamental & Clinical Pharmacology
Stéphane SchückHervé Allain

Abstract

Piribedil is a dopamine agonist acting on D2 and D3 central nervous system dopamine receptors. This drug has been administered to 12 young healthy male volunteers (age 22 +/- 2 years) according to a single center randomized, double-blind, two ways cross-over, placebo controlled trial, including a washout period of one week. Placebo and piribedil were administered by a single intravenous infusion over 2 h (3 mg). Psychomotor performance and cognitive functions were assessed through a standardized and computerized psychometric tests battery and a continuous electroencephalogram (EEG) mapping. Piribedil improved simple reaction time (P=0.02), immediate (P=0.045 and 0.004), and delayed free recall (P=0.05), dual coding test (P=0.02) and increased theta and fast beta waves on the EEG (P < 0.05 and 0.001, respectively). No deleterious effect was observed on the tests exploring attention and concentration via the other procedures. It is concluded that a single intravenous perfusion of piribedil 3 mg improves alertness and the information processing speed within the central nervous system, in healthy volunteers.

References

Jan 1, 1989·Neurobiology of Aging·G L WenkL C Cork
Jul 1, 1985·British Journal of Clinical Pharmacology·A Patat, P Foulhoux
Jan 1, 1988·European Journal of Clinical Pharmacology·A PatatJ Granier
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·R D Oades
Jun 1, 1984·Neurology·R P NewmanD B Calne
Sep 1, 1980·British Journal of Clinical Pharmacology·I Hindmarch
Jan 1, 1995·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H AllainS Belliard
Oct 10, 1996·European Journal of Pharmacology·A CagnottoT Mennini
Oct 20, 1998·Acta Psychiatrica Scandinavica. Supplementum·I Hindmarch
Feb 23, 1999·Dementia and Geriatric Cognitive Disorders·V Thomas-OllivierH Allain
Aug 12, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·I Hindmarch, Z Shamsi
Sep 1, 1999·International Clinical Psychopharmacology·A PatatJ M Gandon
Dec 10, 1999·Brain and Cognition·F H Previc
Jan 15, 2000·Science·J L McGaugh
Aug 25, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·H AllainM Djemai
Sep 5, 2001·The American Journal of Psychiatry·D Nagaraja, S Jayashree

❮ Previous
Next ❯

Citations

Jan 1, 1983·Neuroscience and Biobehavioral Reviews·J N Joyce
Dec 4, 2003·Parkinsonism & Related Disorders·Virgilio Gerald H EvidenteMercedita A Parazo
Sep 25, 2009·The Journal of Neuropsychiatry and Clinical Neurosciences·Ari D KalechsteinAndrew F Leuchter
Feb 1, 2007·Neuropsychiatric Disease and Treatment·Hervé AllainDanièle Bentué-Ferrer
Dec 10, 2013·Expert Opinion on Investigational Drugs·Fabio Blandini, Marie-Therese Armentero
Apr 3, 2003·Human Psychopharmacology·Hervé AllainSerge Belliard
Sep 4, 2007·Neuropsychologia·Alonso MontoyaMartin Lepage
Aug 1, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Fabien GierskiAnne-Marie Ergis
Aug 6, 2013·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Aristea LadasAna B Vivas
Jan 8, 2015·Frontiers in Psychology·Alma GuilbertChristine Moroni
Jun 28, 2016·CNS Drugs·Santiago Perez-Lloret, Olivier Rascol
Nov 3, 2012·Journal of Psychopharmacology·Tanja VeselinovicGerhard Gründer
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Bruno BontempiFrédérique Menzaghi
Mar 20, 2010·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Paul S FosterKenneth M Heilman
Aug 22, 2006·The Journal of Pharmacology and Experimental Therapeutics·Nathalie Turle-LorenzoMarianne Amalric
Jul 27, 2017·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A A Pilipovich, V L Golubev
Dec 20, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A A Pilipovich, O V Vorob'eva
Aug 28, 2021·International Journal of Environmental Research and Public Health·Ilona Poćwierz-Marciniak, Michał Harciarek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.